Miquel Vila Bover I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR) Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca Email Miquel Vila Bover Email Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)
I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder. In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN). I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.
Proyectos Mecanismos moleculares de neurodegeneración ligada a la neuromelanina en la enfermedad de Parkinson y envejecimiento cerebral IP: Miquel Vila Bover Colaboradores: Thais Cuadros Arasa, Helena Xicoy Cortada, Marta González Sepúlveda, Annabelle Parent Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN Financiación: 332750 Referencia: PID2020-116339RB-I00 Duración: 01/09/2021 - 31/08/2024 NIPARK - Targeting neuromelanin-linked neuronal dysfunction and degeneration in ageing and Parkinson’s disease using a combined imaging and brain stimulation approach IP: Miquel Vila Bover Colaboradores: - Entidad financiadora: Instituto de Salud Carlos III Financiación: Referencia: EC/ERANET_JNPD/2020/VILA Duración: - Sex-based modulation of neuromelanin-linked Parkinson’s disease pathology IP: Miquel Vila Bover Colaboradores: Camille Guillard Sirieix Entidad financiadora: Michael J. Fox Foundation Financiación: 163538.22 Referencia: SEX_NEUROMELANINE_MJFF2020 Duración: 01/02/2021 - 31/12/2024 Development of a novel genetically-engineered humanized rodent model to study neuronal dysfunction and neurodegeneration in Parkinson's disease and brain aging IP: Miquel Vila Bover Colaboradores: Joan Compte Barrón, Miriam Izquierdo Sans Entidad financiadora: Fundació "La Caixa" Financiación: 115092 Referencia: CAIXA/INPHINIT/COMPTE Duración: 01/10/2018 - 30/09/2021 Paginación Primera página « Página anterior ‹ Página 1 Página 2 Página actual 3 Página 4 Página 5 … Siguiente página › Última página »
